Scientists uncover two-pronged strategy to overcome glioblastoma's resistance to immunotherapy
Scientists at The Wistar Institute have identified a combination treatment that overcomes two of the biggest barriers to immunotherapy in glioblastoma. In a study published in Neuro-Oncology, the researchers show that reprogramming myeloid cells, a type of immune cell that glioblastoma tumors co-opt to protect…
This is a short extract from a report by Medical Xpress. The full text stays with the publisher — follow the link to read it there.
Read at source
